Scipher Medicine and Maxymune Therapeutics Partner to Advance AI-Driven Target Discovery in Immunology

Scipher Medicine, a pioneer in network-based and AI-driven precision immunology,  announced a strategic collaboration with Maxymune Therapeutics, a ...

September 11, 2025 | Thursday | News
Cytiva Joins Forces with WhiteLab Genomics to Shorten AAV Development Timelines

Collaboration will help reduce stable cell line development timelines in AAV genomic medicine development and ultimately also shorten development timeline ...

September 11, 2025 | Thursday | News
Sapio Sciences and Ultima Genomics Forge Strategic Partnership to Streamline Multi-Omics Research

Sapio Sciences, the science-awareTM lab informatics platform,  announced a strategic partnership with Ultima Genomics. The collaboration will make m...

September 10, 2025 | Wednesday | News
Tolerance Bio and ZipCode Bio Forge Strategic Collaboration to Develop Targeted RNA-Based Thymus Therapeutics

Tolerance Bio, a biopharmaceutical company pioneering innovative approaches to extending healthspan by preserving, restoring, and manipulating the functi...

September 09, 2025 | Tuesday | News
Northstrive Biosciences and Yuva Biosciences Complete Phase II of AI-Driven Drug Discovery Program

Northstrive Biosciences and Yuva Biosciences previously announced the AI Development Program, a collaboration leveraging MitoNova™, YuvaBio&rsquo...

September 08, 2025 | Monday | News
Daiichi Sankyo and Merck Report Positive Phase 2 Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer

Daiichi Sankyo (TSE: 4568) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 2...

September 08, 2025 | Monday | News
CrystalsFirst and NexMR Forge Exclusive Partnership to Accelerate Fragment-Based Drug Discovery

 CrystalsFirst GmbH, a leader in high-performance structural biology services, and NexMR AG, a pioneer in ultrafast NMR screening,  announ...

September 05, 2025 | Friday | News
Science 37 and Catalent Partner to Transform Clinical Trial Access with Direct-to-Patient IMP Delivery

Science 37, the leader in expanding patient access to clinical trials, and Catalent®, a global leader in enabling pharma, biotech, and consumer healt...

September 05, 2025 | Friday | News
Andelyn Biosciences Partners with Tern Therapeutics to Advance Late-Stage Manufacturing of Gene Therapy for CLN2 Batten Disease

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered...

September 05, 2025 | Friday | News
Regenerex Pharma and Holista Colltech Sign Global Supply and Development Agreement for Advanced Wound Care Solutions

Regenerex Pharma, Inc. (OTC: RGPX), a leading innovator in advanced wound closure systems for chronic wounds, today announced that it has entered into a ...

September 04, 2025 | Thursday | News
MEDIPAL and JCR Partner on Global Development of JR-479 for Ultra-Rare GM2 Gangliosidosis

MEDIPAL HOLDINGS CORPORATION (TSE 7459, MEDIPAL) and JCR Pharmaceuticals Co., Ltd. (TSE 4552, JCR) announced that the two companies have signed an exclus...

September 03, 2025 | Wednesday | News
Ryvu Partners with BioNTech to Accelerate Oncology Clinical Trial Access in Poland

Ryvu to support BioNTech in the acceleration of site activation and enrollment of patients for multiple of BioNTech’s priority oncology clin...

September 03, 2025 | Wednesday | News
Roche and Alnylam Target Uncontrolled Hypertension with ZENITH Phase III Trial

Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 In the Phase II KA...

September 02, 2025 | Tuesday | News
Foresight Diagnostics Reaches Licensing Agreement with Roche on PhasED-Seq™, Resolving Litigation

Foresight Diagnostics ("Foresight") announced that it has entered into a limited licensing agreement with Roche Molecular Systems and Roche Sequencing Sy...

September 01, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close